Blueberry and cardiovascular disease risk factors: A systematic review and meta-analysis of randomized controlled trials

•As, no meta-analysis of trials on CVD risk factors using blueberries has been performed to date, we conducted such analysis of published randomized controlled trials to investigate the overall effect of supplementation with blueberry on CVD risk factors including anthropometric indices, lipid profi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Complementary therapies in medicine 2020-09, Vol.53, p.102389-102389, Article 102389
Hauptverfasser: Miraghajani, Mayam, Momenyan, Somayeh, Arab, Arman, Hasanpour Dehkordi, Ali, Symonds, Micheal E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•As, no meta-analysis of trials on CVD risk factors using blueberries has been performed to date, we conducted such analysis of published randomized controlled trials to investigate the overall effect of supplementation with blueberry on CVD risk factors including anthropometric indices, lipid profiles, glycemic indices, and inflammatory related factors among adults.•Our analysis covers wide range of CVD risk factors including anthropometric indices (BMI, WC and weight), lipid profiles (HDL, LDL, TC, and TG), glycemic indices (FBS, and insulin) , and inflammatory factors (CRP, and TNF-α).•Our results showed that supplementation with blueberry caused a marginal significant reduction in TG, whilst subgroup analysis supported a beneficial on weight, and CRP. Cardiovascular disease (CVD) remains an important cause of mortality and morbidity that can be prevented by the consumption of healthy foods. These include blueberry, a dark coloured berry containing extremely high amounts of functional ingredients. We therefore examined the extent to which supplementation with blueberry effects on CVD risk indices. We searched the ISI Web of Science, Scopus, PubMed and Cochrane Library on March 2020 and checked reference lists from primary studies and review articles for any additional studies. No language restrictions were applied. All randomized and controlled clinical trials (RCTs) using blueberry supplements to modify CVD risk factors were included in our analysis. Mean Difference (MD) was pooled using a random effects model and 11 studies were included in the final analysis. Pooled effect size showed that supplementation with blueberry had a small insignificant effect in reducing plasma triglycerides (MD = −0.27 mmol/l; 95 % CI: −0.57, 0.17, p = 0.06). Although current study found no differences between blueberry and control groups for any other outcomes, subgroup analysis suggested a favourable impact of blueberry on reducing body weight. Significant weight loss was indicated from studies longer with a follow up of more than 6 weeks or with blueberry powder or freeze-dried blueberry. Current evidence is insufficient to show a benefit of blueberry supplements in modifying CVD risk factors across a variety of adult populations. Robust data and larger studies are required to assess potential effects.
ISSN:0965-2299
1873-6963
DOI:10.1016/j.ctim.2020.102389